Target
Programmed cell death 1 ligand 1
Ligand
BDBM649681
Substrate
n/a
Meas. Tech.
Affinity Test Between the Compounds of the Invention and hPD-L1 Protein
Kd
50±n/a nM
Citation
 XU, YZHANG, HZHU, QDU, HXIA, YYU, CHUANG, SLI, HZOU, Y NOVEL BIPHENYL DERIVATIVE AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF US Patent  US20240043392 Publication Date 2/8/2024 
Target
Name:
Programmed cell death 1 ligand 1
Synonyms:
B7 homolog 1 | B7-H1 | B7H1 | B7H1 | CD274 | CD_antigen=CD274 | PD-L1 | PD1L1_HUMAN | PDCD1 ligand 1 | PDCD1L1 | PDCD1LG1 | PDL1 | Programmed cell death 1 ligand 1 | Programmed death ligand 1
Type:
PROTEIN
Mol. Mass.:
33278.49
Organism:
Homo sapiens (Human)
Description:
ChEMBL_109807
Residue:
290
Sequence:
MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET
  
Inhibitor
Name:
BDBM649681
Synonyms:
2-(((1-(3-((3′-((2-chloro-4-(((2-hydroxyethyl)amino) methyl)-5-methoxyphenoxy)methyl)-2,2′-dimethyl-[1,1′-biphenyl]-3-yl)oxy)propyl)-1H-1,2,3-triazol-4-yl)methyl))ethyl-1-ol | US20240043392, Compound II-9
Type:
Small organic molecule
Emp. Form.:
C33H40ClN4O5
Mol. Mass.:
608.147
SMILES:
COc1cc(OCc2cccc(c2C)-c2cccc(OCCCn3cc(CC[CH]O)nn3)c2C)c(Cl)cc1CNCCO |^1:28|
Structure:
Search PDB for entries with ligand similarity: